NATASHA SRA: Open Payments
NPI 1194353607 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 23 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $180 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $180 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| ACADIA Pharmaceuticals Inc | 2 | $44 |
| Alkermes, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, Jornay PM, NUPLAZID, VIVITROL, AUSTEDO XR, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
